bevacizumab,trifluridine tipiracil
roche,servier,taiho pharma,otsuka
[]
sunlight study #gi23 for 3rd line therapy in colorectal cancer using longsurf &amp; bevacizumab demonstrated superior os, pfs compared to ftp/tpi alone. no response differences based on kras mutation status or tumor location #colorectalcancer #crcsm 
The Colorectal Cancer Alliance is a national nonprofit fiercely dedicated to ending colorectal cancer within our lifetime. #TomorrowCantWait